Articles by Peter Whoriskey

We found 1 results.


As Drug Industry’s Influence over Research Grows, So Does the Potential for Bias
Peter Whoriskey – The Washington Post, 3 Dec 2012

For drugmaker GlaxoSmithKline, the 17-page article in the New England Journal of Medicine represented a coup. The 2006 report described a trial that compared three diabetes drugs and concluded that Avandia, the company’s new drug, performed best. A Food and Drug Administration scientist estimated, four years later, that the drug had been associated with 83,000 heart attacks and deaths.

→ read full article